US2022162569A1PendingUtilityA1

Recombinant flavin-adenine dinucleotide glucose dehydrogenase and uses thereof

Assignee: B G NEGEV TECHNOLOGIES AND APPLICATIONS LTD AT BEN GURION UNIVPriority: Aug 2, 2017Filed: Feb 15, 2022Published: May 26, 2022
Est. expiryAug 2, 2037(~11 yrs left)· nominal 20-yr term from priority
G01N 27/3271C07K 2319/61C12N 15/62A61B 5/1486C12Q 1/006C07K 14/80C12Y 101/05C07K 2319/00C12N 9/0006
62
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

A recombinant protein, including: (a) alpha subunit of an FAD-GDH; and (b) a minimal cytochrome c peptide is provided. Additionally, an electrode coupled to a recombinant protein, the recombinant protein made of: (a) a cofactor of a redox enzyme; (b) a redox enzyme; (c) a linker moiety configured to link any one of: the cofactor or the enzyme to an electron transfer (ET) domain; and (d) an ET domain, is also provided. Methods for: (a) transferring an electron to an electrode, by coupling the recombinant protein an electrode; and (b) quantifying the amount of an analyte e.g., glucose are also provided.

Claims

exact text as granted — not AI-modified
What is claimed is: 
     
         1 . A recombinant protein, comprising: (a) alpha subunit of a flavin adenine dinucleotide-glucose dehydrogenase (FAD-GDH); and (b) a minimal c-type cytochrome peptide. 
     
     
         2 . The recombinant protein of  claim 1 , wherein said alpha subunit of an FAD-GDH is a  Burkholderia  cepacian alpha subunit of an FAD-GDH. 
     
     
         3 . The recombinant protein of  claim 1 , wherein said minimal C-type cytochrome peptide is a cytochrome second magnetochrome domain (MCR-2) from magnetosome protein MamP. 
     
     
         4 . The recombinant protein of  claim 1 , further being bound to a porphyrin comprising a metal. 
     
     
         5 . The recombinant protein of  claim 1 , further being bound to a compound of formula I: 
       
         
           
           
               
               
           
         
         wherein said R is any electron donor, said compound of formula I is bound to a metal. 
       
     
     
         6 . The recombinant protein of  claim 4 , wherein said metal is a trivalent metal or a divalent metal. 
     
     
         7 . The recombinant protein of  claim 1 , comprising an amino acid sequence selected from the group consisting of: SED ID NOs: 10-13. 
     
     
         8 . The recombinant protein of  claim 1 , wherein said alpha subunit of said FAD-GDH comprises the amino acid sequence set forth in SEQ ID NO: 8. 
     
     
         9 . The recombinant protein of  claim 1 , further comprising a substitution of at least one amino acid residue of said alpha subunit of said FAD-GDH, said minimal c-type cytochrome peptide, or both, with a non-canonical amino acid residue. 
     
     
         10 . The recombinant protein of  claim 9 , being coupled to an electrode via said non-canonical amino acid (ncAA) residue. 
     
     
         11 . A composition comprising the recombinant protein of  claim 1  and the gamma subunit of an FAD-GDH. 
     
     
         12 . A DNA molecule comprising a nucleotide sequence encoding the recombinant protein of  claim 1 . 
     
     
         13 . The DNA molecule of  claim 12 , comprising a nucleic acid sequence selected from the group consisting of: SEQ ID NOs: 6, 7, and 10. 
     
     
         14 . An expression vector comprising the DNA molecule of  claim 12 . 
     
     
         15 . A cell comprising the DNA molecule of  claim 12 . 
     
     
         16 . A method for transferring an electron to an electrode, comprising coupling the recombinant protein of  claim 9  to an electrode, wherein the recombinant protein is further bound to porphyrin comprising a metal, thereby transferring an electron to said electrode.

Join the waitlist — get patent alerts

Track US2022162569A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.